欧洲益生菌婴儿和儿童配方奶粉市场预测至 2028 年 - COVID-19 影响和按类型（婴儿配方奶粉（0-1 岁）和成长配方奶粉（1-6 岁））和分销渠道（在线和离线）
No. of Pages: 78 | Report Code: BMIRE00027436 | Category: Consumer Goods
No. of Pages: 78 | Report Code: BMIRE00027436 | Category: Consumer Goods
职业女性人口激增
母乳是婴儿的理想食品，因为它安全、清洁，并且含有有助于预防许多常见儿童疾病的抗体。母乳为孩子提供出生后头几个月所需的所有能量和营养，并继续提供孩子一半或更多的营养需求。根据各种调查和报告，由于各种原因，包括妇女加入劳动力市场，母乳喂养正在下降。例如，根据英国国家统计局（ONS）的数据，母亲的就业统计数据从2000年的66.2%增长到2019年的75.1%。因此，女性劳动力参与率的提高正在减少母乳喂养，并导致母乳喂养率下降。推动对益生菌婴儿和儿童配方奶粉的需求。根据 CDC 的数据，17% 的婴儿在出生后的头两天补充配方奶，约 35% 的 6 个月以上婴儿喂养母乳和配方奶。因此，参与劳动力市场的女性人数的增加正在推动欧洲益生菌婴儿和儿童配方奶粉市场的增长。
市场概览
欧洲益生菌婴幼儿配方奶粉市场分为德国、法国、意大利、英国、俄罗斯和欧洲其他地区。生育率上升推动了市场增长。根据欧盟委员会的数据，欧盟的总和生育率从2001年的每名女性1.43个活产婴儿增加到2020年的每名女性1.50个活产婴儿。此外，婴儿配方奶粉和成长配方奶粉主要被职业母亲使用，以提供健康的营养。以及婴儿的营养食品。对婴儿护理和营养的日益关注、生活方式的改变、中产阶级人口的增加以及经济体（包括英国、德国和法国）人们购买力和可支配收入的增加预计将推动益生菌婴儿和儿童配方奶粉市场的发展预测期内欧洲的增长。
欧洲益生菌婴幼儿配方奶粉市场细分
欧洲益生菌婴儿和儿童配方奶粉市场按类型、分销渠道和国家/地区进行细分。
根据类型，市场分为婴儿配方奶粉（0- 1年）和成长配方（1-6年）。成长配方奶粉（1-6岁）细分市场在2022年占据了较大的市场份额。根据分销渠道，市场分为线上和线下。 2022年，线下细分市场占据更大的市场份额。根据国家/地区，市场分为德国、法国、意大利、英国、俄罗斯和欧洲其他地区。 2022 年，俄罗斯占据市场份额主导地位。 SA ; HiPP 有限公司Vertrieb KG 公司；雅培实验室和美赞臣公司Company, LLC 是该地区经营益生菌婴儿和儿童配方奶粉的领先公司。
Strategic insights for Europe Probiotic Infant and Child Formula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 826.43 Million |
| Market Size by 2028 | US$ 1,755.33 Million |
| Global CAGR (2022 - 2028) | 13.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Probiotic Infant and Child Formula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Probiotic Infant and Child Formula Market is valued at US$ 826.43 Million in 2022, it is projected to reach US$ 1,755.33 Million by 2028.
As per our report Europe Probiotic Infant and Child Formula Market, the market size is valued at US$ 826.43 Million in 2022, projecting it to reach US$ 1,755.33 Million by 2028. This translates to a CAGR of approximately 13.4% during the forecast period.
The Europe Probiotic Infant and Child Formula Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Probiotic Infant and Child Formula Market report:
The Europe Probiotic Infant and Child Formula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Probiotic Infant and Child Formula Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Probiotic Infant and Child Formula Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Probiotic Infant and Child Formula Market
